1![Vision Improvement After Retreatment with an Oral Synthetic cis-Retinoid (QLT091001) in Subjects with Inherited Retinal Disease caused by Mutations in RPE65 or LRAT On behalf of the RET IRD 02 Study Group: Hendrik P.N. Vision Improvement After Retreatment with an Oral Synthetic cis-Retinoid (QLT091001) in Subjects with Inherited Retinal Disease caused by Mutations in RPE65 or LRAT On behalf of the RET IRD 02 Study Group: Hendrik P.N.](https://www.pdfsearch.io/img/8547e2fa4a26df65f0d767555baa2bb7.jpg) | Add to Reading ListSource URL: www.qltinc.comLanguage: English - Date: 2015-06-06 02:10:51
|
---|
2![Microsoft Word - IRDDNA140821.doc Microsoft Word - IRDDNA140821.doc](https://www.pdfsearch.io/img/8bc7a24a7c679eb01ad0242766c42229.jpg) | Add to Reading ListSource URL: www.scgh.health.wa.gov.auLanguage: English - Date: 2014-08-28 04:22:42
|
---|
3![Molecular Vision 2013; 19:[removed] <http://www.molvis.org/molvis/v19/2312> Received 31 July 2013 | Accepted 14 November 2013 | Published 16 November 2013 © 2013 Molecular Vision Retinal pigment epithelium protein of 6 Molecular Vision 2013; 19:[removed] <http://www.molvis.org/molvis/v19/2312> Received 31 July 2013 | Accepted 14 November 2013 | Published 16 November 2013 © 2013 Molecular Vision Retinal pigment epithelium protein of 6](https://www.pdfsearch.io/img/041f01608936816ff19db4c58a9de5c7.jpg) | Add to Reading ListSource URL: www.molvis.orgLanguage: English - Date: 2013-11-16 12:00:51
|
---|
4![Identifying photoreceptors in blind eyes caused by RPE65 mutations: Prerequisite for human gene therapy success Samuel G. Jacobson*†, Tomas S. Aleman*, Artur V. Cideciyan*, Alexander Sumaroka*, Sharon B. Schwartz*, Eli Identifying photoreceptors in blind eyes caused by RPE65 mutations: Prerequisite for human gene therapy success Samuel G. Jacobson*†, Tomas S. Aleman*, Artur V. Cideciyan*, Alexander Sumaroka*, Sharon B. Schwartz*, Eli](https://www.pdfsearch.io/img/b69a50f0c0a9be85eb89373c481f97e1.jpg) | Add to Reading ListSource URL: www.pnas.orgLanguage: English - Date: 2011-08-19 00:43:09
|
---|
5![Media
Inquiries:
Jessica
Rowlands
202-‐729-‐4089
[removed]
Spark
Therapeutics
Receives
FDA
Breakthrough
Therapy
Designation
f Media
Inquiries:
Jessica
Rowlands
202-‐729-‐4089
[removed]
Spark
Therapeutics
Receives
FDA
Breakthrough
Therapy
Designation
f](https://www.pdfsearch.io/img/614c21ced44c7ed39f43556966611f9a.jpg) | Add to Reading ListSource URL: www.sparktx.comLanguage: English - Date: 2014-11-25 08:45:10
|
---|
6![Media Inquiries: Jessica Rowlands[removed]removed] Spark Therapeutics Raises $72.8 Million in Oversubscribed Financing Media Inquiries: Jessica Rowlands[removed]removed] Spark Therapeutics Raises $72.8 Million in Oversubscribed Financing](https://www.pdfsearch.io/img/63376490f8fa2e20f22d348021580e00.jpg) | Add to Reading ListSource URL: www.sparktx.comLanguage: English - Date: 2014-05-27 14:36:51
|
---|
7![RETINITIS PIGMENTOSA RESEARCH ADVANCES Landmark Gene Therapy Restores Vision in Children and Young Adults More than 40 children and young RETINITIS PIGMENTOSA RESEARCH ADVANCES Landmark Gene Therapy Restores Vision in Children and Young Adults More than 40 children and young](https://www.pdfsearch.io/img/42f2c709b53b396589c6f910bb8f0e7f.jpg) | Add to Reading ListSource URL: www.blindness.orgLanguage: English - Date: 2014-09-23 13:27:53
|
---|
8![Molecular Vision 2003; 9:601-5 <http://www.molvis.org/molvis/v9/a73> Received 17 July 2003 | Accepted 24 October 2003 | Published 11 November 2003 Molecular Vision 2003; 9:601-5 <http://www.molvis.org/molvis/v9/a73> Received 17 July 2003 | Accepted 24 October 2003 | Published 11 November 2003](https://www.pdfsearch.io/img/916d242a04d1b5b96ba4a75211880ee3.jpg) | Add to Reading ListSource URL: www.molvis.orgLanguage: English - Date: 2011-04-21 16:15:33
|
---|